Literature DB >> 9084071

Imipramine and mirtazapine are less effective than expected.

R M Pinder, M Zivkov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9084071     DOI: 10.1007/s002130050195

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  7 in total

Review 1.  Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring.

Authors:  S H Preskorn
Journal:  J Clin Psychiatry       Date:  1989-07       Impact factor: 4.384

2.  The randomized concentration-controlled trial: an evaluation of its sample size efficiency.

Authors:  L P Sanathanan; C C Peck
Journal:  Control Clin Trials       Date:  1991-12

Review 3.  Concentration-controlled trials. What does the future hold?

Authors:  A Johnston; D W Holt
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

Review 4.  The implication of concentration/response studies of tricyclic antidepressants for psychiatric research and practice.

Authors:  S H Preskorn; D S Mac
Journal:  Psychiatr Dev       Date:  1984

5.  Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.

Authors:  R Davis; M I Wilde
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

6.  A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients.

Authors:  J A Bruijn; P Moleman; P G Mulder; W W van den Broek; A M van Hulst; R C van der Mast; B J van de Wetering
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

Review 7.  Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group.

Authors:  P Vestergaard; L F Gram; P Kragh-Sørensen; P Bech; N Reisby; T G Bolwig
Journal:  Psychopharmacol Ser       Date:  1993
  7 in total
  1 in total

Review 1.  Mirtazapine: a review of its use in major depression.

Authors:  K J Holm; A Markham
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.